Literature DB >> 12384478

Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice.

Judy R Freshour1, Sharon E Chase, Karen L Vikstrom.   

Abstract

Gender differences have been described in the response of the cardiovascular system to a number of stimuli, including ventricular remodeling in response to pressure overload, but the molecular basis for these differences remains unclear. Because gender differences in the cardiac expression of angiotensin-converting enzyme (ACE) could contribute to differences in myocardial remodeling, we examined myocardial ACE expression in age-matched male and female mice. Ventricular ACE was more abundant in male than female mice at both mRNA and protein levels. These differences became apparent once the mice reached sexual maturity and became more pronounced with increasing age. The influence of mouse gonadal status on ventricular ACE expression was also examined. Oophorectomy slightly increased ACE levels in female mice, whereas ventricular ACE levels were substantially decreased in androgen-deprived males. The antithetical changes in ventricular ACE abundance seen in agonadal male and female mice suggest that testosterone as well as estrogen may play a role in regulating ACE expression in the heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384478     DOI: 10.1152/ajpheart.01054.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  16 in total

Review 1.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

2.  Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats.

Authors:  Vijayakumar Chinnathambi; Amar S More; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2014-05-22       Impact factor: 4.285

3.  Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.

Authors:  A Bukowska; L Spiller; C Wolke; U Lendeckel; S Weinert; J Hoffmann; P Bornfleth; I Kutschka; A Gardemann; B Isermann; A Goette
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-29

4.  Sex differences in acute ANG II-mediated hemodynamic responses in mice.

Authors:  Markus P Schneider; Paul F Wach; Melissa K Durley; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-23       Impact factor: 3.619

5.  Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.

Authors:  Tammy M Brady; Jennifer Roem; Christopher Cox; Michael F Schneider; Amy C Wilson; Susan L Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Am J Kidney Dis       Date:  2020-05-07       Impact factor: 8.860

6.  Sex differences in the drinking response to angiotensin II (AngII): Effect of body weight.

Authors:  Jessica Santollo; Ann-Marie Torregrossa; Derek Daniels
Journal:  Horm Behav       Date:  2017-06-03       Impact factor: 3.587

7.  Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.

Authors:  Karen E Binkley
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

8.  Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.

Authors:  Yakhin Shimoni; Xiu-Fang Liu
Journal:  J Physiol       Date:  2003-05-30       Impact factor: 5.182

9.  Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life.

Authors:  Kai Chen; Jianli Bi; Yixin Su; Mark C Chappell; James C Rose
Journal:  Reprod Sci       Date:  2015-08-04       Impact factor: 3.060

Review 10.  Genetic modification of hypertension by sGCα1.

Authors:  Patrick Y Sips; Emmanuel S Buys
Journal:  Trends Cardiovasc Med       Date:  2013-06-05       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.